脳梗塞急性期STA-MCAバイパス術後の過灌流症候群の検討
スポンサーリンク
概要
- 論文の詳細を見る
Object : While there are only a handful of reports in the literature detailing hyperperfusion syndrome (HPS) occurring in the chronic stage of a brain infarction after STA-MCA bypass, there are even fewer detailing its occurrence in the acute stage. If we opt to perform an STA-MCA bypass in the acute stage to minimalize any possible extension of the lesion, it seems reasonable to assume that there is a greater risk of hyperperfusion syndrome, as the cerebral perfusion pressure is lower than that in the chronic stage. To test this assumption, we compared the incidence of hyperperfusion syndrome after STA-MCA bypasses performed in both the acute and chronic stages. Patients and Methods : Over a 4-year period, from April 1st 2002 to May 10th 2006, we performed 53 STA-MCA bypasses, 23 in the acute stage and 32 in the chronic stage. Each case was examined by IMP or Xe SPECT within 2 weeks of the bypass surgery. Where hyperperfusion was evident, cases were divided into one of two groups, according to the location of the hyperperfusion : Group A demonstrating it locally, and Group B demonstrating it hemispherically. Symptomatic cases were also divided into two groups according to the degree of severity, with the mild group exhibiting such things as headaches or transient psychological disturbance, and the severe group reporting convulsions or conscious disturbance etc. Results : Of the 23 acute stage bypasses, 7 cases (30.4%) were classified as Group A and 2 cases (8.7%) as Group B, affecting 9/23 cases, or 39.1% of the acute total. Of these, there were 3 mild symptomatic cases (13.0%), and 1 severe case (4.3%). Of the chronic stage bypasses, 4 cases (12.5%) were classified as Group A and 1 case (3.1%) as Group B, affecting 5/32 cases, or 15.6% of the chronic total. Of these, there was 1 mild symptomatic case (3.1%), and 2 severe cases (6.3%). There were no hemorrhagic transformations. According to these results, acute stage bypasses were not significantly different to chronic ones with regard to the occurrence of symptomatic cases. (p=0.435; Fisher exact method) Conclusion : There were more cases of hyperperfusion in acute stage bypasses than in chronic stage bypasses, but there was no significant difference in symptomatic rates. This implies that it may be feasible to safely perform STA-MCA bypasses in the acute stage without undue concern for the occurrence of hyperperfusion syndrome.
- 2007-03-01
論文 | ランダム
- 当院における廃棄血の現状解析
- 血液製剤の使用を拒否した破傷風患者の1例
- 告知欄 血液製剤の安全性の向上及び安定供給の確保を図るための基本的な方針(基本方針)の全部を改正する件について
- 時の判例 HIV(ヒト免疫不全ウイルス)に汚染された非加熱血液製剤を投与された患者がエイズ(後天性免疫不全症候群)を発症して死亡した薬害事件について,厚生省薬務局生物製剤課長であった者に業務上過失致死罪の成立が認められた事例--最二小決平成20.3.3
- 実例から学ぶ・医薬品のライフサイクルマネジメント(第9回)血液製剤によるHIV感染(2)